LEADART BIOTECHNOLOGIES

A Probe for Every Protein, LeadArt has established a unique and growing active probe library (>4000), and invented the world's first automated platform for chemical proteomics. By combining cutting-edge biotechnology and advanced automation technology, LeadArt is aspired to speed up the exploration of the whole human proteome and discover active probes for most of the 20,000 human proteins. For the first time in the world, LeadArt is building the largest and high-quality protein-probe binding database in the world, and accelerating the drug discovery for more than 3,000 undruggable or difficult-to-drug targets... LeadArt established state-of-art photoaffinity labeled chemical proteomics (PAL-AfBPP) technology platform and built robust protocols to obtain high quality data. LeadArt PAL-AfBPP technology is a universal tool to study the mechanism of action of drugs in the human living cell system: map the complicated drug-protein interactions, reveal the potential drug target, discover..

Also known as: LeadArt Biotechnologies, Inc.